Abstract: This invention encompasses the novel compounds of Formula I, which are useful in the treatment of caspase-3 mediated diseases.
The invention also encompasses certain pharmaceutical compositions comprising compounds of Formula I as well as methods for treatment of caspase-3 mediated diseases.
Type:
Grant
Filed:
September 7, 2001
Date of Patent:
February 25, 2003
Assignee:
Merck Frosst Canada & Co.
Inventors:
Yongxin Han, Andre Giroux, Erich L. Grimm, Renee Aspiotis, Cameron Black